U.S. Oil and Gas Stock News

Potential The Bancorp, Inc. ( NASDAQ:TBBK ) shareholders may wish to note that the Independent Director, Mark Tryniski...

Kornit Digital Ltd.'s ( NASDAQ:KRNT ) price-to-sales (or "P/S") ratio of 3.1x may not look like an appealing investment...

Investors in GE HealthCare Technologies Inc. ( NASDAQ:GEHC ) had a good week, as its shares rose 2.1% to close at...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see ResMed Inc...

RMR Group's (NASDAQ:RMR) stock is up by a considerable 16% over the past week. However, we decided to pay attention to...

Unfortunately for some shareholders, the Sagtec Global Limited ( NASDAQ:SAGT ) share price has dived 26% in the last...

It is hard to get excited after looking at Cadre Holdings' (NYSE:CDRE) recent performance, when its stock has declined...

Clean Energy Fuels Corp. ( NASDAQ:CLNE ) shareholders would be excited to see that the share price has had a great...

Texas Pacific Land Corporation ( NYSE:TPL ) shares have had a really impressive month, gaining 30% after a shaky period...

Despite an already strong run, Transcat, Inc. ( NASDAQ:TRNS ) shares have been powering on, with a gain of 27% in the...

Tredegar Corporation ( NYSE:TG ) shares have continued their recent momentum with a 26% gain in the last month alone...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Crescent Energy Company ( NYSE:CRGY ) shareholders would be excited to see that the share price has had a great month...

While Taylor Devices, Inc. ( NASDAQ:TAYD ) might not have the largest market cap around , it received a lot of...

Despite an already strong run, Pangaea Logistics Solutions Ltd. ( NASDAQ:PANL ) shares have been powering on, with a...

To the annoyance of some shareholders, Reitar Logtech Holdings Limited ( NASDAQ:RITR ) shares are down a considerable...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

The BlueLinx Holdings Inc. ( NYSE:BXC ) share price has done very well over the last month, posting an excellent gain...

i3 Verticals (IIIV) opened fiscal Q1 2026 with revenue of US$52.7 million and basic EPS of US$0.03, while net income excluding extra items came in at US$0.6 million. The company has seen quarterly revenue move between US$46.2 million and US$61.7 million over the past two years, with basic EPS ranging from a loss of US$0.58 to a profit of US$0.54. This latest print lands in the middle of its recent earnings range and keeps the focus firmly on how margins are evolving from here. See our full...

Synaptics (SYNA) just posted Q2 2026 results with revenue of US$302.5 million and a basic EPS loss of US$0.38, while net income excluding extra items came in at a loss of US$14.8 million, keeping profitability under pressure. Over the past few quarters, revenue has moved from US$267.2 million in Q2 2025 to US$266.6 million in Q3, US$282.8 million in Q4, US$292.5 million in Q1 2026 and now US$302.5 million. Over the same period, EPS has swung from a small profit of US$0.05 in Q2 2025 to losses...

ConocoPhillips (COP) has just wrapped up FY 2025 with Q4 revenue of US$13.7b and basic EPS of US$1.17, alongside net income excluding extra items of US$1.4b. This puts fresh numbers on the table for investors watching its earnings power. Over recent quarters, the company has seen revenue move from US$14.7b and EPS of US$1.90 in Q4 2024 to a FY 2025 trajectory that includes US$16.9b of revenue and EPS of US$2.23 in Q1 2025, before settling at the latest Q4 run rate. With trailing 12 month net...

DNOW Inc. ( NYSE:DNOW ) shareholders have had their patience rewarded with a 28% share price jump in the last month...

Cousins Properties (CUZ) has wrapped up FY 2025 with Q4 revenue of US$261.2 million and a basic EPS loss of US$0.02, alongside a funds from operations loss of US$358.9 million that puts the quarter firmly in the red for shareholders. Over recent periods, the company has seen revenue move from US$223.3 million in Q4 2024 to US$248.4 million in Q1 2025 and US$238.5 million in Q2 2025 before reaching US$245.6 million in Q3 2025, while quarterly basic EPS ranged from earnings of US$0.12 in Q1...

Ardelyx recently announced dosing of the first patient in ACCEL, a Phase 3 trial of IBSRELA (tenapanor) in adults with chronic idiopathic constipation, while also securing a new U.S. patent extending oral formulation protection for IBSRELA and XPHOZAH to 2042. The combination of advancing IBSRELA into a large new indication and lengthening patent protection may reshape how long Ardelyx’s medicines can remain differentiated in the market. With the new 2042 formulation patent as a backdrop,...